These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 7640539)

  • 21. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000.
    Khoshnood B; De Vigan C; Vodovar V; Goujard J; Goffinet F
    BJOG; 2004 May; 111(5):485-90. PubMed ID: 15104615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down's syndrome with conventional non-invasive testing technology.
    Hu H; Jiang Y; Zhang M; Liu S; Hao N; Zhou J; Liu J; Zhang X; Ma L
    Exp Biol Med (Maywood); 2017 Mar; 242(5):547-553. PubMed ID: 28056555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down's syndrome screening: a controversial test, with more controversy to come!
    Reynolds TM
    J Clin Pathol; 2000 Dec; 53(12):893-8. PubMed ID: 11265172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Explaining variation in Down's syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews.
    Crombag NM; Vellinga YE; Kluijfhout SA; Bryant LD; Ward PA; Iedema-Kuiper R; Schielen PC; Bensing JM; Visser GH; Tabor A; Hirst J
    BMC Health Serv Res; 2014 Sep; 14():437. PubMed ID: 25257793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal genetic services for Down's syndrome: access and provision in 1990-1991. Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
    Williamson P; Harris R; Church S; Fiddler M; Rhind J
    Br J Obstet Gynaecol; 1996 Jul; 103(7):676-83. PubMed ID: 8688395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevention of Down's syndrome in the south western region of England 1975-1985.
    Wilson N; Bickley D; McDermott A
    West Engl Med J; 1990 Mar; 105(1):15-7. PubMed ID: 2141994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An economic appraisal of alternative pre-natal screening programmes for Down's syndrome.
    Shackley P; McGuire A; Boyd PA; Dennis J; Fitchett M; Kay J; Roche M; Wood P
    J Public Health Med; 1993 Jun; 15(2):175-84. PubMed ID: 7688977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antenatal screening for Down's syndrome with the quadruple test.
    Wald NJ; Huttly WJ; Hackshaw AK
    Lancet; 2003 Mar; 361(9360):835-6. PubMed ID: 12642052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of differences in the distribution of maternal age in England and Wales on the performance of prenatal screening for Down's syndrome.
    Huang T; Watt HC; Wald NJ
    Prenat Diagn; 1997 Jul; 17(7):615-21. PubMed ID: 9249861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk assessment adjusted for gestational age in maternal serum screening for Down's syndrome.
    Gardosi J; Mongelli M
    BMJ; 1993 Jun; 306(6891):1509-11. PubMed ID: 8518678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for Down's syndrome using an iso-risk curve based on maternal age and serum alpha-fetoprotein level.
    Tabor A; Larsen SO; Nielsen J; Nielsen J; Philip J; Pilgaard B; Videbech P; Nørgaard-Pedersen B
    Br J Obstet Gynaecol; 1987 Jul; 94(7):636-42. PubMed ID: 2441737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second trimester screening for Down's syndrome: 7 years experience.
    Beaman JM; Goldie DJ
    J Med Screen; 2001; 8(3):128-31. PubMed ID: 11678551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic assessment of maternal serum screening for Down's syndrome using human chorionic gonadotropin.
    Seror V; Muller F; Moatti JP; Le Gales C; Boue A
    Prenat Diagn; 1993 Apr; 13(4):281-92. PubMed ID: 8506230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.